Increased potency and functional persistence in vitro of a next-generation ny-eso-1-specific tcr therapy incorporating gen-r-tm genetic reprogramming technology
JOURNAL FOR IMMUNOTHERAPY OF CANCER(2022)
AI Read Science
Must-Reading Tree
Example

Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined